These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2951304)

  • 1. [The cholinergic component of airway obstruction].
    Ulmer WT; Schwabl U
    Fortschr Med; 1987 Jan; 105(3):43-7. PubMed ID: 2951304
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of the cholinergic system for respiratory tract obstruction].
    Ulmer WT; Zimmermann I; Marek W; Islam MS
    Prax Klin Pneumol; 1988 Jul; 42(7):498-501. PubMed ID: 3186645
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bronchodilator effectiveness of theophylline].
    Kleinemeier HJ; Höltmann B; Schwabl U; Schwabl H; Ulmer WT
    Fortschr Med; 1988 Aug; 106(24):499-502. PubMed ID: 2975627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
    Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
    Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fenoterol in the treatment of bronchial obstruction in chronic asthmatiform bronchitis].
    Montanari S; Pasqua F; Gramiccioni E
    Clin Ter; 1982 Jul; 102(2):131-8. PubMed ID: 6216039
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
    Langaker O
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of fenoterol, ipratropium bromide and their combination in patients with bronchial asthma.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1988; 30(2):98-102. PubMed ID: 2976027
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients].
    Bezel R; Brändli O; Braun P; Haegi V; Helcl J; Villiger B
    Schweiz Rundsch Med Prax; 1987 May; 76(22):632-6. PubMed ID: 2956661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bronchodilation effects of aminophylline, fenoterol and their combination].
    Mayer M; Dúbravová H
    Bratisl Lek Listy; 1982 Sep; 78(3):323-33. PubMed ID: 7139383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of ipratropium bromide in aerosol administration on airway resistance and MEFV curves].
    Illiano A; Tranfa CM; Giacomelli P; Cantatore D; Donato Di Paola RM; Marsico SA
    Arch Monaldi; 1981; 36(3):105-17. PubMed ID: 6216870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Are changes in airway resistance revealed by the pneumosonogram sufficiently specific?].
    Cegla UH; Navarro C
    Med Klin; 1981 May; 76(11):324-5. PubMed ID: 6454059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Responder and non-responder in the bronchodilator test?].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Nov; 49(11):584-9. PubMed ID: 8584530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The respiratory resistance response to salbutamol measured by the "opening interruptor" technic].
    Rebić P; Mandarić D; Radosavljević G
    Plucne Bolesti; 1986; 38(3-4):276-81. PubMed ID: 3588752
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between indicators of respiratory tract patency and intrapulmonary distribution of ventilation in patients with chronic obstructive bronchopulmonary disease after combined administration of aminophylline and fenoterol].
    Mayer M; Dúbrava I; Strmen J; Dúbravová H
    Bratisl Lek Listy; 1987 May; 87(5):606-15. PubMed ID: 3651856
    [No Abstract]   [Full Text] [Related]  

  • 20. Is nocturnal asthma caused by changes in airway cholinergic activity?
    Catterall JR; Rhind GB; Whyte KF; Shapiro CM; Douglas NJ
    Thorax; 1988 Sep; 43(9):720-4. PubMed ID: 2973665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.